Finasteride
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | |||
| - | |||
<table align='right' border=1> | <table align='right' border=1> | ||
<tr><td> | <tr><td> | ||
| Line 12: | Line 10: | ||
</td></tr></table> | </td></tr></table> | ||
==Description== | ==Description== | ||
| + | [http://crdd.osdd.net/raghava/hmrbase/test_extract.php?&db=arun&table=nphormonet&id=1243&show=SHOW-3D Show 3-D Structure] | ||
| + | |||
An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia. | An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia. | ||
==General Properties== | ==General Properties== | ||
| Line 56: | Line 56: | ||
*[http://www.drugbank.ca/drugs/DB01216]Drugbank | *[http://www.drugbank.ca/drugs/DB01216]Drugbank | ||
| - | [[ | + | [[Category:Hormones]] |
| + | [[Category:HMRbase]] | ||
Current revision
|
|
Contents |
[edit] Description
An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia.
[edit] General Properties
*Molecular Weight
372.54
*Molecular Formula
C23H36N2O2
*IUPAC NAME
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
*Canonical Smiles
CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C
*Isomeric Smiles
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
[edit] PhysioChemical Properties
*Melting Point
3.03(EXP)
*LogP
11.7(EST) at 25C
*Water Solubility
